White House Says It Will Meet Vaccine Goals Despite Pause In Johnson & Johnson Use
The NPR Politics Podcast
00:00
Intro
This chapter covers the public health announcement recommending a pause on the Johnson & Johnson COVID-19 vaccine due to rare blood clot cases in women. It highlights the CDC and FDA's precautionary measures and the need for careful tracking of vaccine history in patients experiencing such complications.
Play episode from 00:00
Transcript
